Development of a safer new treatment for Systemic Lupus Erythematosus that preserves B cell immunity
Development of a safer new treatment for Systemic Lupus Erythematosus that preserves B cell immunity
批准号:
nhmrc : 1113659
负责人:
Prof Fabienne Mackay
金额:
$46.1万
依托单位国家:
澳大利亚
项目类别:
Development Grants
财政年份:
2016
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2016-01-01 至 2018-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Lupus is an illness characterized by the body’s immune system attacking the body itself. More than 5 millions of people worldwide suffer from lupus, in particular Indigenous Australians who are 4 times more likely to develop lupus. Current treatments are toxic and/or lack efficacy. In this proposal we use strong new evidence from the laboratory to support the design of a much safer and more effective treatment for lupus that will be validated for future use in patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a safer new treatment for Systemic Lupus Erythematosus that preserves B cell immunity
-
批准号:nhmrc : GNT1113659
-
项目类别:Development Grants
-
资助金额:$67.2万
-
财政年份:2016
-
负责人:Prof Fabienne Mackay
-
依托单位:
Research Fellowship
-
批准号:nhmrc : 1020630
-
项目类别:Research Fellowships
-
资助金额:$45.06万
-
财政年份:2012
-
负责人:Prof Fabienne Mackay
-
依托单位:
The role of BAFF, its receptor TACI and Toll-like receptors in Autoimmunity and Tolerance.
-
批准号:nhmrc : 1008520
-
项目类别:NHMRC Project Grants
-
资助金额:$32.46万
-
财政年份:2011
-
负责人:Prof Fabienne Mackay
-
依托单位:
Research Fellowship - Grant ID:427608
-
批准号:nhmrc : 427608
-
项目类别:NHMRC Research Fellowships
-
资助金额:$41.26万
-
财政年份:2007
-
负责人:Prof Fabienne Mackay
-
依托单位:
海外基金